
NLS Pharmaceutics AG – NASDAQ:NLSPW
NLS Pharmaceutics AG stock price today
NLS Pharmaceutics AG stock price monthly change
NLS Pharmaceutics AG stock price quarterly change
NLS Pharmaceutics AG stock price yearly change
NLS Pharmaceutics AG key metrics
Market Cap | 8.17M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -1.17 |
Revenue | N/A |
EBITDA | -18.59M |
Income | -20.03M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNLS Pharmaceutics AG stock price history
NLS Pharmaceutics AG stock forecast
NLS Pharmaceutics AG financial statements
Jun 2022 | 0 | -8.64K | |
---|---|---|---|
Dec 2022 | 0 | -7.85M | |
Jun 2023 | 0 | -7.61M | |
Dec 2023 | 0 | -4.55M |
Jun 2022 | 2058049 | 6.09M | 296.37% |
---|---|---|---|
Dec 2022 | 9276643 | 5.99M | 64.63% |
Jun 2023 | 2270146 | 6.55M | 288.83% |
Dec 2023 | 1846641 | 10.68M | 578.36% |
Jun 2022 | -7.66K | 4.07M | 3.58K |
---|---|---|---|
Dec 2022 | -6.21M | -7.59M | 13.80M |
Jun 2023 | -7.29M | 0 | 0 |
Dec 2023 | -2.38M | 0 | 1.63M |
NLS Pharmaceutics AG other data
-
What's the price of NLS Pharmaceutics AG stock today?
One share of NLS Pharmaceutics AG stock can currently be purchased for approximately $0.02.
-
When is NLS Pharmaceutics AG's next earnings date?
Unfortunately, NLS Pharmaceutics AG's (NLSPW) next earnings date is currently unknown.
-
Does NLS Pharmaceutics AG pay dividends?
No, NLS Pharmaceutics AG does not pay dividends.
-
How much money does NLS Pharmaceutics AG make?
NLS Pharmaceutics AG has a market capitalization of 8.17M.
-
What is NLS Pharmaceutics AG's stock symbol?
NLS Pharmaceutics AG is traded on the NASDAQ under the ticker symbol "NLSPW".
-
What is NLS Pharmaceutics AG's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of NLS Pharmaceutics AG?
Shares of NLS Pharmaceutics AG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When NLS Pharmaceutics AG went public?
NLS Pharmaceutics AG is publicly traded company for more then 4 years since IPO on 29 Jan 2021.
NLS Pharmaceutics AG company profile:
NASDAQ
0
Biotechnology
Healthcare
NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company also developing NLS-4, a selective dopamine reuptake inhibitor to prevent rare sleep disorders; NLS-3, a repurposed reverse ester of methylphenidate for treatment of ADHD; NLS-8, a melatonin ML1A receptor agonist, improved scopolamine-induced amnesia; NLS-11, a norepinephrine and dopamine reuptake inhibitor and muscarinic M1, M2, M3 receptor antagonist; and NLS-12, a norepinephrine and dopamine reuptake inhibitor and muscarinic M4 receptor antagonist. NLS Pharmaceutics AG was incorporated in 2015 and is based in Zurich, Switzerland.
,
CIK: 0001783036
ISIN: CH0573155204
: